Palbociclib

Overview

Palbociclib is an orally available cyclin-dependent kinase (CDK) inhibitor with potential antineoplastic activity. Palbociclib selectively inhibits cyclin-dependent kinase 4 (CDK4) and 6 (CDK6), thereby inhibiting retinoblastoma (Rb) protein phosphorylation early in the G1 phase leading to cell cycle arrest.

Application

Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Cancer | CDK

Product Information

• Catalog No.: B0084-456204
• CAS No.: 571190-30-2
• Molecular Formula: C24H29N7O2
• Molecular Weight: 447.53
• Purity: 98%
• Storage: Store at 2-8°C
• Solubility: Soluble in Chloroform (Slightly), DMSO (Slightly, Heated), Methanol (Slightly, Heated)

Source

Original product source